Financial reports
20-F
2023 FY
Annual report (foreign)
4 Apr 24
20-F
2022 FY
Annual report (foreign)
29 Mar 23
20-F
2021 FY
Annual report (foreign)
24 Mar 22
20-F
2020 FY
Annual report (foreign)
26 Mar 21
20-F
2019 FY
Annual report (foreign)
1 Apr 20
20-F
2018 FY
Annual report (foreign)
1 Apr 19
20-F
2017 FY
Annual report (foreign)
20 Mar 18
Current reports
6-K
Report of Foreign Private Issuer
25 Sep 24
6-K
Report of Foreign Private Issuer
20 Aug 24
6-K
Collplant Biotechnologies Reports 2024 Second Quarter Financial Results and Provides Corporate Update
20 Aug 24
6-K
CollPlant and Stratasys Announce Pre-clinical Study for Regenerative Commercial-Sized Breast Implants
19 Aug 24
6-K
CollPlant Biotechnologies Unveils Inaugural ESG and Sustainability Report
29 Jul 24
6-K
CollPlant Successfully Bio-Prints 200cc Commercial-Size Regenerative Breast Implants and Reports Additional Positive Pre-Clinical Data
6 Jun 24
6-K
CollPlant Biotechnologies Announces First Quarter Financial Results For 2024 and Provides Corporate Update
29 May 24
6-K
Collplant Biotechnologies Reports 2023 Full Year Financial Results and Provides Corporate Update
4 Apr 24
6-K
CollPlant Issues Letter to Shareholders
15 Feb 24
6-K
CollPlant Biotechnologies Begins Preclinical Trial with Commercial-Size, Regenerative Breast Implants
2 Jan 24
Registration and prospectus
S-8
Registration of securities for employees
29 May 24
S-8
Registration of securities for employees
18 Apr 23
F-3
Shelf registration (foreign)
30 Dec 22
S-8
Registration of securities for employees
25 Mar 22
424B5
Prospectus supplement for primary offering
16 Feb 21
S-8
Registration of securities for employees
28 Aug 20
424B3
Prospectus supplement
5 Jun 20
F-3
Shelf registration (foreign)
27 May 20
D
$4.45M in equity, sold $4.45M, 14 investors
9 Mar 20
D
$3.5M in debt / options / securities to be acquired, sold $3.5M, 8 investors
10 Sep 19
Proxies
No filings
Other
EFFECT
Notice of effectiveness
13 Jan 23
CORRESP
Correspondence with SEC
9 Jan 23
UPLOAD
Letter from SEC
6 Jan 23
CT ORDER
Confidential treatment order
18 Aug 21
EFFECT
Notice of effectiveness
8 Jun 20
CORRESP
Correspondence with SEC
4 Jun 20
UPLOAD
Letter from SEC
4 Jun 20
CT ORDER
Confidential treatment order
23 Apr 19
EFFECT
Notice of effectiveness
22 Apr 19
CORRESP
Correspondence with SEC
18 Apr 19
Ownership
SC 13G/A
Roumell Asset Management, LLC
13 Feb 24
SC 13G/A
Loewenbaum Lilian S.
25 Jan 24
144
Notice of proposed sale of securities
22 Sep 23
144
Notice of proposed sale of securities
12 Sep 23
SC 13G/A
MEITAV INVESTMENT HOUSE LTD
24 Jul 23
144
Notice of proposed sale of securities
14 Jun 23
SC 13G
Roumell Asset Management, LLC
13 Feb 23
SC 13G/A
INVESTMENT MANAGEMENT OF VIRGINIA LLC
30 Jan 23
SC 13G/A
Loewenbaum Lilian S.
25 Jan 23
SC 13G/A
MEITAV DASH INVESTMENTS LTD
11 Jan 23